Oral Humira Biosimilar Could Be A Game-Changer, Says Rani CEO

Talat Imran Talks About Rani Therapeutics’ RaniPill Robotic Capsule For Biologics

 
• By Dave Wallace
  
Talat Imran, Rani Therapeutics
Talat Imran sees significant advantages for oral delivery of biosimilars via robotic capsules • Source: Rani Therapeutics

More from Biosimilars

More from Products